Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cytokinetics, Incorporated - Common Stock
(NQ:
CYTK
)
37.93
-1.55 (-3.93%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cytokinetics, Incorporated - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Cytokinetics Inc. (NASDAQ: CYTK) Leading the Way in Thursday Trading Based on Percentage Gain
December 21, 2023
Via
Investor Brand Network
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 21, 2023
Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
December 14, 2023
Via
Benzinga
Expert Ratings for Cytokinetics
November 09, 2023
Via
Benzinga
Expert Ratings for Cytokinetics
October 09, 2023
Via
Benzinga
Where Cytokinetics Stands With Analysts
August 22, 2023
Via
Benzinga
Where Cytokinetics Stands With Analysts
August 04, 2023
Via
Benzinga
Potential Takeover In Works for Cardiovascular Treatment Focused Cytokinetics
November 01, 2023
Cytokinetics Inc (NASDAQ: CYTK), a late-stage biotech company focused on cardiovascular treatments, is reportedly exploring potential takeover options as it has garnered interest from at least one...
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for Cytokinetics: Here's What You Need To Know
October 20, 2023
Via
Benzinga
Union Pacific To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday
October 20, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 10, 2023
Via
Benzinga
NuScale Power, Stagwell And Other Big Stocks Moving Higher On Friday
October 06, 2023
U.S. stocks traded higher, with the Nasdaq Composite gaining around 50 points on Friday. Here are some big stocks recording gains in Friday's session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
11 Analysts Have This to Say About Cytokinetics
June 20, 2023
Via
Benzinga
What 20 Analyst Ratings Have To Say About Cytokinetics
May 22, 2023
Via
Benzinga
Why CalAmp Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
October 06, 2023
Gainers
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 05, 2023
Via
Benzinga
The 3 Best Mid-Cap Stocks to Buy Now: September 2023
September 07, 2023
With the best mid-cap stocks to buy, investors get the best of both worlds: an established business but with ample room to grow.
Via
InvestorPlace
18 Analysts Have This to Say About Cytokinetics
May 05, 2023
Via
Benzinga
Cytokinetics: Q1 Earnings Insights
May 04, 2023
Via
Benzinga
Analyst Ratings for Cytokinetics
April 18, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 05, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023
August 15, 2023
Via
Benzinga
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
August 04, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Analyst Expectations for Cytokinetics's Future
March 31, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
July 26, 2023
Wednesday saw 59 companies set new 52-week lows.
Via
Benzinga
5 Biotech Stocks That Could Soar Thanks To These Disruptive Healthcare Technologies
June 20, 2023
Via
Benzinga
Cytokinetics Plans To Discontinue Late-Stage ALS Trial Due To Futility
March 31, 2023
Cytokinetics Incorporated (NASDAQ: CYTK) announced that the Data Monitoring Committee (DMC) for COURAGE-ALS recently convened to conduct the second planned interim analysis of this Phase 3 clinical...
Via
Benzinga
Analyst Ratings for Cytokinetics
March 06, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
July 24, 2023
On Monday morning, 70 companies achieved new lows for the year.
Via
Benzinga
Cytokinetics Posts Aficamten Data In Patients With Thickened Heart Muscle
March 06, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.